GlassScriptPhysician profile
Robert F Greiner
NPI 1295885853
$16,824.03
in general payments reported to CMS, 2019-2025
40 companies · $1,597 in 2025
The $1,597 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $846 · 2020: $629 · 2021: $2,736 · 2022: $5,124 · 2023: $2,386 · 2024: $3,505 · 2025: $1,597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,703 · Travel and Lodging: $1,596 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,702.96 |
| Travel and Lodging | $1,595.70 |
| Education | $189.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $3,009.83 | 2019-2022 | |
| Electronic Waveform Lab, INC. | $2,387.90 | 2021-2025 | |
| Kerecis Limited | $1,896.43 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $1,820.71 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, N/A, Real Intelligence |
| Titan Surgical Group, LLC | $1,315.23 | 2022-2025 | |
| Stryker Corporation | $1,248.44 | 2019-2024 | Blueprint Patient Specific Instrumentation, Mako, Stryker |
| Tenex Health INC. | $719.36 | 2021 | |
| Medacta USA, INC. | $466.36 | 2024 | |
| Zimmer Biomet Holdings, INC. | $377.06 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $345.63 | 2021-2025 | Euflexxa |
| Horizon Therapeutics Plc | $234.20 | 2019-2022 | |
| Kci USA, INC. | $221.60 | 2021-2023 | Prevena, V.A.C. Veraflo |
| Dynasplint Systems INC. | $200.20 | 2019-2025 | Dynasplint |
| Biowound Solutions, INC. | $193.78 | 2025 | Bio-Connekt |
| Ortho Systems | $189.60 | 2024 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $178.67 | 2021 | |
| Acumed LLC | $178.41 | 2024-2025 | Acumed, Innate Implant, Acumed |
| Organogenesis INC. | $172.34 | 2021-2022 | |
| Trice Medical, INC. | $171.49 | 2022 | |
| Bioventus LLC | $154.56 | 2019-2025 | Xcell, Durolane, Exogen Ultrasound Bone Healing System |
| Orthalign INC | $154.35 | 2025 | Orthalign Plus |
| Maxx Orthopedics, INC. | $138.98 | 2019 | |
| Conformis, INC. | $133.43 | 2022 | |
| Ermi LLC | $130.76 | 2019 | |
| Exactech, INC. | $114.94 | 2023 | |
| Medtronic, INC. | $109.12 | 2022 | |
| Depuy Synthes Sales INC. | $107.42 | 2021-2025 | Orthovisc, Monovisc, Peak |
| Linvatec Corporation | $68.58 | 2025 | Biobrace 23mm |
| Fidia Pharma USA INC. | $63.40 | 2025 | Hymhyn |
| Kowa Pharmaceuticals America, INC. | $55.51 | 2022-2023 | Seglentis |
| Innovation Technologies INC | $42.50 | 2021 | |
| Sanofi-Aventis U.S. LLC | $41.10 | 2019 | |
| Pfizer INC. | $34.83 | 2019-2020 | |
| Nevro Corp. | $29.31 | 2023 | Senza |
| Acelrx Pharmaceuticals, INC. | $27.75 | 2020 | |
| Abbott Laboratories | $27.58 | 2022 | |
| Biotissue Holdings INC. | $21.72 | 2023 | |
| Globus Medical, INC. | $19.28 | 2025 | Onvoy |
| Merck Sharp & Dohme LLC | $12.70 | 2022 | |
| Sonex Health, INC. | $8.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Greiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.